PDUFA III Includes Risk Management Fees For “Peri-Approval” Phase

The FDA/industry PDUFA III agreement includes funding to expand FDA's Office of Drug Safety by 100 full-time equivalent staff positions over five years

More from Archive

More from Pink Sheet